| Gene Name | Gene Symbol | Locus ID | References |
| cadherin 1, type 1, E-cadherin (epithelial) | CDH1 | 999 | 9 |
| excision repair cross-complementing rodent repair deficiency, complementation group 5 (xeroderma pigmentosum, complementation group G (Cockayne syndrome)) | ERCC5 | 2073 | 1 |
| p53-induced protein PIGPC1 | PIGPC1 | 64065 | 1 |
| tumor necrosis factor receptor superfamily, member 6 | TNFRSF6 | 355 | 1 |
| tumor protein p53 (Li-Fraumeni syndrome) | TP53 | 7157 | 53 |
| phosphatase and tensin homolog (mutated in multiple advanced cancers 1) | PTEN | 5728 | 18 |
| mitogen-activated protein kinase kinase 4 | MAP2K4 | 6416 | 1 |
| annexin A7 | ANXA7 | 310 | 1 |
| WAP four-disulfide core domain 1 | WFDC1 | 58189 | 1 |
| cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | CDKN2A | 1029 | 14 |
| spectrin SH3 domain binding protein 1 | SSH3BP1 | 10006 | 1 |
| synaptopodin 2 | SYNPO2 | 171024 | 1 |
| predisposing for prostate cancer | PCAP | 7834 | 3 |
| breast cancer 1, early onset | BRCA1 | 672 | 8 |
| catenin (cadherin-associated protein), alpha 1 (102kD) | CTNNA1 | 1495 | 2 |
| CCCTC-binding factor (zinc finger protein) | CTCF | 10664 | 2 |
| Putative prostate cancer tumor suppressor | N33 | 7991 | 2 |
| kangai 1 (suppression of tumorigenicity 6, prostate; CD82 antigen (R2 leukocyte antigen, antigen detected by monoclonal and antibody IA4)) | KAI1 | 3732 | 4 |
| inhibin, alpha | INHA | 3623 | 2 |
| retinoblastoma 1 (including osteosarcoma) | RB1 | 5925 | 5 |
| neurofilament, light polypeptide (68kD) | NEFL | 4747 | 1 |
| steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2) | SRD5A2 | 6716 | 13 |
| fragile site, folic acid type, rare, fra(7)(p11.2) | FRA7A | 2408 | 1 |
| MAX interacting protein 1 | MXI1 | 4601 | 4 |
